AI & ChatGPT searches , social queries for ANTI VEGF
Search references for ANTI VEGF. Phrases containing ANTI VEGF
See searches and references containing ANTI VEGF!
Search references for ANTI VEGF. Phrases containing ANTI VEGF
See searches and references containing ANTI VEGF!ANTI VEGF
Medication which blocks growth of blood vessels
Anti–vascular endothelial growth factor therapy, also known as anti-VEGF (/vɛdʒˈɛf/) therapy or medication, is the use of medications that block vascular
Anti-VEGF
Diabetes-induced damage to the retina of the eye
such as vascular endothelial growth factor (VEGF), angiopoietin-2 (Ang-2), and interleukin-6 (IL-6). Anti-VEGF mAbs like bevacizumab (used off-label), ranibizumab
Diabetic_retinopathy
Route of administration
doubled to 2 million just 3 years later in 2011 when aflibercept (another anti-VEGF intravitreal injection) became available for the treatment of wet AMD
Intravitreal_administration
Protein involved in blood vessel growth
Vascular endothelial growth factor (VEGF, /vɛdʒˈɛf/), originally known as vascular permeability factor (VPF), is a signal protein produced by many cells
Vascular endothelial growth factor
Vascular_endothelial_growth_factor
Group of eye diseases related to poor retinal and nerve perfusion
that anti-VEGF medications are effective either for short-term or for longer-term treatment. The short, medium, and long-term safety of anti-VEGF treatment
Glaucoma
Canadian ophthalmologist
growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for
Joan_Miller_(ophthalmologist)
Medical condition
treatment for CNV is to inhibit VEGF activity by competing the binding of VEGF with specific neutralizing anti-VEGF antibody. VEGF inhibitors include pegaptanib
Corneal_neovascularization
Medical condition
of anti-VEGF therapy in the uveitis treatment regimen can be fully determined. The anti VEGF agents furthermore have not been shown to have an anti-inflammatory
Punctate_inner_choroiditis
Substance that inhibits the growth of new blood vessels
of bleeding induced by anti-VEGF agents are complicated and not yet totally understood, the most accepted hypothesis is that VEGF could promote endothelial
Angiogenesis_inhibitor
Medication
vessels by inhibiting vascular endothelial growth factor A (VEGF-A), in other words anti–VEGF therapy. Bevacizumab was approved for medical use in the United
Bevacizumab
Damage to the retina of the eyes
Vascular endothelial growth factor (VEGF) seems to play a vital role in promoting neovascularization. Using anti-VEGF drugs (antibodies to sequester the
Retinopathy
Pharmaceutical compound
synergistic with anti–VEGF-A therapies because it targets and neutralizes VEGF-C and VEGF-D, while anti–VEGF-A drugs inhibit only VEGF-A; this combined
Sozinibercept
Vision loss due to damage to the macula of the eye
to support the use of modern stereotactic radiotherapy combined with anti-VEGF is currently uncertain and is awaiting the results of ongoing studies
Macular_degeneration
Procedure widely used in eye surgery
less than in the past for age-related macular degeneration in favor of anti-VEGF drugs. The American Academy of Ophthalmology practice guidelines recommend
Laser_coagulation
Italian-American molecular biologist
(AMD), and diabetic retinopathy. At Genentech, he discovered VEGF—and made the first anti-VEGF antibody—which suppresses growth of a variety of tumors. These
Napoleone_Ferrara
Creation of new blood vessels in the choroid layer of the eye
with intravitreal injections of angiogenesis inhibitors (also known as "anti-VEGF" drugs) to control neovascularization and reduce the area of fluid below
Choroidal_neovascularization
Pharmaceutical drug
growth factor (VEGF) inhibitor used to treat neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME). The anti-VEGF was approved
Conbercept
Class of pharmaceutical drugs
only inhibits EGFR). Several trials are investigating the combination of anti-VEGF antibody bevacizumab with ALK inhibitors such as alectinib and brigatinib
ALK_inhibitor
Disease of the retina affecting central vision
injections of anti-VEGF agents, namely bevacizumab, a humanized monoclonal antibody targeted against pro-angiogenic, circulatory VEGF; and ranibizumab
Macular_telangiectasia
Type of virus
combination with several cancer chemotherapies. The anti-angiogenesis drug bevacizumab (anti-VEGF antibody) has been shown to reduce the inflammatory
Oncolytic_virus
Medical condition
targeted agents, such as targeted cancer therapies, immunotoxins, and anti-VEGF therapy. Bacterial toxins are the primary cause of one category of thrombotic
Thrombotic_microangiopathy
Blood vessel formation, when new vessels emerge from existing vessels
retinal fluids leak into the retina, causing loss of vision. Anti-angiogenic drugs targeting the VEGF pathways are now used successfully to treat this type of
Angiogenesis
Protein involved in blood vessel growth
Vascular endothelial growth factor A (VEGF-A) is a protein that in humans is encoded by the VEGFA gene. The chemical formula is C3914H6252N1212O1278S52
Vascular endothelial growth factor A
Vascular_endothelial_growth_factor_A
massive reduction in vision due to bleeding and scarring of the macula. Anti-VEGF therapy, which is injected directly into the eye (intravitreally), has
Pachychoroid disorders of the macula
Pachychoroid_disorders_of_the_macula
Oligonucleotide or peptide molecules that bind specific targets
Cunningham ET, Guyer DR, Adamis AP (February 2006). "Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease". Nature Reviews. Drug Discovery.
Aptamer
Medical condition
vessels, which provide necessary elements to the tumor for tumor survival. Anti-VEGF agents such as pazopanib are approved for use in carcinomas and in soft
Epithelioid_sarcoma
Blockage of the central retinal vein in the eye
thrombosis) in patients with retinal vascular occlusion. Treatment consists of Anti-VEGF drugs like Lucentis or intravitreal steroid implant (Ozurdex) and Pan-Retinal
Central retinal vein occlusion
Central_retinal_vein_occlusion
Genetic disorder affecting blood vessel development
Several anti-angiogenesis drugs approved for other conditions, such as cancer, have been investigated in small clinical trials. The anti-VEGF antibody
Hereditary hemorrhagic telangiectasia
Hereditary_hemorrhagic_telangiectasia
Smallest type of blood vessel
retinal disorder, neovascular age-related macular degeneration, local anti-VEGF therapy to limit the bio-activity of vascular endothelial growth factor
Capillary
Medical condition
intracranial pressure and haemorrhage, with options like vitrectomy or anti-VEGF injections for persistent eye bleeds. The prognosis depends on the severity
Terson_syndrome
Medical condition
mechanism of action and duration of anti-VEGF effect on macular edema is currently unknown. The intraocular levels of VEGF are increased in eyes with macular
Branch_retinal_vein_occlusion
American biotechnology corporation
progressive multifocal leukoencephalopathy. 2004: Avastin (bevacizumab): Anti-VEGF monoclonal antibody for the treatment of metastatic cancer of the colon
Genentech
Medication for macular degeneration
bispecific monoclonal antibody to target both vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang-2). By targeting these pathways, faricimab stabilizes
Faricimab
Pathological conditions of the kidney, impairing the organ's ability to filter blood
and chronic kidney injuries. Newer agents such as anti-vascular endothelial growth factor (anti-VEGF) are also associated with similar injuries, as well
Kidney_disease
Type of eye cancer
S.K. Steven; M. Villegas, Victor; Gold, Aaron; G. Murray, Timothy. "Anti-VEGF Therapy Shows Benefit in the Treatment of Radiation Maculopathy". Retina
Uveal_melanoma
Part of the eye
modalities of management for retinal disease: Intravitreal medication, such as anti-VEGF or corticosteroid agents Vitreoretinal surgery Use of nutritional supplements
Retina
Medicinal chemical compound, steroid
reducing macular edema. Drug trials have found it to be as efficient as anti-VEGF drugs in eyes with artificial lenses over a two-year period. A systematic
Triamcinolone_acetonide
Group of diseases involving cell growth
PMID 19360048. Bagri A, Kouros-Mehr H, Leong KG, Plowman GD (March 2010). "Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale". Trends in Molecular
Cancer
Benign tumor of the vestibulocochlear cranial nerve
the glycoprotein named VEGF (vascular endothelial growth factor) that initiates proliferation was discovered. An anti-VEGF drug named bevacizumab (Avastin)
Vestibular_schwannoma
Medical condition
immune checkpoint inhibitor-based combinations, such as anti-PD-(L)1 agents combined with anti-VEGF therapy or dual immune checkpoint blockade, as the preferred
Liver_cancer
Eye disease affecting the choroid
observation, photodynamic therapy, thermal laser, intravitreal injection of anti-VEGF therapy, or combination therapy. In PCV, sudden blurring of vision or
Polypoidal choroidal vasculopathy
Polypoidal_choroidal_vasculopathy
Medication
and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy. The earlier generation
Fruquintinib
Swiss multinational pharmaceutical corporation
to market Ophthotech's Fovista (an anti-PDGF aptamer, also being investigated for use in combination with anti-VEGF treatments) outside the U.S. for up
Novartis
American ophthalmologist
Vascular endothelial growth factor (VEGF) in rapidly developing "wet" Macular Degeneration, which led to anti-VEGF therapy, which is widely used in western
Patricia_D'Amore
Medical condition
any additional benefit of combining anti-VEGF and intravitreal steroids when compared to either treatment alone. Anti‐tumour necrosis factor agents have
Macular_edema
Gonadotropin that regulates the development of reproductive processes
of FSH and FSH-receptor antagonists as an anti-tumor angiogenesis therapy (cf. avastin for current anti-VEGF approaches). EFSH, a follicle-stimulating
Follicle-stimulating_hormone
Medical condition
of nevi can be treated using anti-VEGF agents, injected through the veins. These drugs inactivate the growth factor (VEGF) to reduce neovascularization
Choroidal_nevus
Treatment for blindness
frequency of anti-VEGF injections. Delivered as a single intravitreal injection, Ixo-vec enables sustained release of aflibercept, an anti-VEGF protein that
Gene therapy of the human retina
Gene_therapy_of_the_human_retina
Intravitreal injections are already commonly used for administering drugs like anti-VEGF agents, making the procedure familiar to clinicians and safer for patients
Intravitreal_gene_therapy
American medical science award
Napoleone Ferrara Discovery of VEGF as a major mediator of angiogenesis and the development of an effective anti-VEGF therapy for wet macular degeneration
Lasker_Award
Pharmaceutical drug
endothelial growth factor (VEGF). Aflibercept is a recombinant fusion protein consisting of the extracellular domains of human VEGF receptor 1 and 2 fused
Aflibercept
Perceiving objects as abnormally small
You've Never Heard Of[permanent dead link] Ozkiris A (January 2010). "Anti-VEGF agents for age-related macular degeneration". Expert Opinion on Therapeutic
Micropsia
Eye disorder found in prematurely-born babies
children treated for ROP are followed yearly. Follow-up after laser or anti-VEGF treatment is individualized. Follow-up of premature children (with or
Retinopathy_of_prematurity
Iranian-American ophthalmologist and retina surgeon known for inventing LASIK eye surgery
Intravitreal slow-release Rock inhibitors alone or in combination with Anti-VEGF Artificial Retina Stimulation Semiconductor photodiode stimulation of
Gholam_A._Peyman
Irish ophthalmologist
cost-effectiveness, patient experience and acceptability of anti-VEGF therapies versus combined anti-VEGF therapy and subthreshold micropulse laser (SML) for
Noemi_Lois
Chemical compound
receptors, upregulating expression of vascular endothelial growth factor (VEGF), and stimulation of the DNA salvage pathway. The primary mechanism of action
Polydeoxyribonucleotide
Treatment of cancer using drugs that inhibit cell division or kill cells
JN (August 2009). "Adverse effects of anticancer agents that target the VEGF pathway". Nature Reviews. Clinical Oncology. 6 (8): 465–77. doi:10.1038/nrclinonc
Chemotherapy
Mammalian protein found in Homo sapiens
inhibited metastasis in an in vivo study and also when hybridized with the anti-VEGF antibody bevacizumab . At least one clinical trial is exploring the use
Osteopontin
Medical intervention
Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent". Investigative Ophthalmology & Visual Science. 59 (15): 5854–5861
Electroretinography
Drugs to suppress IL-6 signalling
disease stabilization via IL-6-regulated downregulation of CCL2, CXCL12 and VEGF. Tocilizumab was first used in large-cell lung carcinoma. In phase I/II trial
Anti-interleukin-6
Protein-coding gene in the species Homo sapiens
angiogenesis via promote VEGF production from cancer cells and it has been shown that IL-17A also mediates tumor resistance to anti-VEGF therapy through the
Interleukin-17A
Medical condition
caution if contemplating the therapeutic use of bevacizumab, other anti-VEGF compounds, or anti-angiogenesis agents in general, which have been associated with
Large-cell lung carcinoma with rhabdoid phenotype
Large-cell_lung_carcinoma_with_rhabdoid_phenotype
Medical condition
PMID 15923510. Finger, PT; Mukkamala, SK (Jul–Aug 2011). "Intravitreal anti-VEGF bevacizumab (Avastin) for external beam related radiation retinopathy"
Radiation_retinopathy
Degeneration of the macula
the actual cause. Photothermal laser ablation, photodynamic therapy, anti-VEGF therapy, or a combination of these are the treatment options of choroidal
Fuchs_spot
Medical condition
photocoagulation (PRP), or injection of anti-VEGF medications with subsequent PRP. The injection blocks the direct effect of VEGF and acts more quickly but will
Rubeosis_iridis
Medical condition of lack of oxygen in the tissues
numerous pro-angiogenic genes, including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and angiopoietins, which promote
Hypoxia_(medicine)
Medical condition
Nonetheless, evidence indicates that combining chemotherapy with the humanized anti-VEGF monoclonal antibody, bevacizumab, in the treatment of recurrent, persistent
Ovarian squamous cell carcinoma
Ovarian_squamous_cell_carcinoma
platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), human chorionic gonadotropin (hcG, banned in men only), somatotrophin (growth
List of drugs banned by the World Anti-Doping Agency
List_of_drugs_banned_by_the_World_Anti-Doping_Agency
Class of pharmaceutical drugs
involved in tumor, including proliferation, metastasis and angiogenesis. The VEGF receptor family contains three members, which are all receptor tyrosine kinases
VEGFR-2_inhibitor
Pharmaceutical drug
degeneration: a meta-analysis of dose effects and comparison with no anti-VEGF treatment and bevacizumab". Journal of Clinical Pharmacy and Therapeutics
Ranibizumab
South Korean pharmaceutical company
markets. SCD411 is a biosimilar referencing Regeneron and Bayer's Eylea, an anti-VEGF therapy indicated for neovascular age-related macular degeneration (wet
Sam_Chun_Dang_Pharm
Genetic disease in which elastic fibers in certain tissues harden
Herrmann, Philipp; Holz, Frank G.; Pfau, Kristina (September 2024). "Anti-VEGF Treatment for Secondary Neovascularization in Pseudoxanthoma Elasticum
Pseudoxanthoma_elasticum
Fissures in Bruch's membrane within the eye's retina
metamorphopsia. If choroidal neovascularization is present, treatment options like anti-VEGF medication, laser photocoagulation, photodynamic therapy, transpupillary
Angioid_streaks
American pharmaceutical company
oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild-type, an anti-EGFR therapy. On February 25, 2013, the FDA approved
Onyx_Pharmaceuticals
Blood vessels in the eye
Jain, Sandeep; Azar, Dimitri T. (2012). "Corneal Neovascularization: An Anti-VEGF Therapy Review". Survey of Ophthalmology. 57 (5): 415–429. doi:10.1016/j
Pericorneal_plexus
Protein-coding gene in the species Homo sapiens
Soluble NRP1 has the opposite effect of membrane bound NRP1 and has anti-VEGF activity. In vivo mouse studies have shown that injections of sNRP-1 inhibits
Neuropilin_1
Loss of visual acuity associated with illness or aging
macula. Vision can often be regained with prompt eye injections with anti-VEGF agents. Giant cell arteritis should be considered in an older person with
Acute_visual_loss
working at Genentech. He is credited with developing a whole new class of anti-VEGF drugs for cancer treatment. He had a leading role in the development of
List of Italian inventions and discoveries
List_of_Italian_inventions_and_discoveries
Experimental gene therapy
(2021-04-01). "Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular
Ixoberogene_soroparvovec
American biologist and geneticist
Aleksander S. (2013-06-05). "Effect of Tumor Microenvironment on Tumor VEGF During Anti-VEGF Treatment: Systems Biology Predictions". JNCI: Journal of the National
Stacey_Finley
atypical hemolytic uremic syndrome. Newer agents such as anti-vascular endothelial growth factor (anti-VEGF) are also associated with similar injuries, as well
Onconephrology
Medical condition
increased ocular hypertension is currently unknown. Research suggests that anti-VEGF drugs and infectious keratitis can elevate intraocular pressure. The condition
Ocular_hypertension
Psychophysical test
patients, leads to early treatment (such as intravitreal injection of anti-VEGF factors, e.g. bevacizumab or ranibizumab) and prevents loss of vision
Preferential hyperacuity perimetry
Preferential_hyperacuity_perimetry
Hans-Peter; Ferrara, Napoleone (29 July 2007). "Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells". Nature Biotechnology
Host response to cancer therapy
Host_response_to_cancer_therapy
Protein that in humans is encoded by the IL33 gene
and thus impaired vision. Current treatment includes administration of anti-VEGF but is not sufficient. Retinal pigment epithelial cells can express IL-33
Interleukin_33
U.S. health institute
no effect on the risk, onset, progression, or severity of retinopathy. Anti-VEGF therapy for diabetic retinopathy: This two-year, NEI-supported study,
National_Eye_Institute
carcinoma (cisplatinum/gemcitabine) Squamous cell carcinoma (no bevacizumab/anti-VEGF in cavitary or in near large vessels Vincent MD (August 2009). "Optimizing
HOHMS
Chemical compound
ovarian cancer, renal cell carcinoma in patients that were unsuccessful on anti-VEGF treatments, metastatic pancreatic cancer, advanced brain tumors, and relapsed
RO4929097
Medical condition
growth factor (VEGF) is known to be associated with sea fan lesions which are types of neovascularization. Bevacizumab is an anti-VEGF drug used in intravitreal
Sickle_cell_retinopathy
Protein-coding gene in the species Homo sapiens
associated angiogenesis research and may represent an alternative to anti-VEGF for tumor treatment. In normal vertebrate embryo development, TMEM230
TMEM230
Ocular route of drug administration
depending on the type of AMD. This disease is treated through an injection of anti-VEGF medication or corticosteroids into the SCS. Diabetic retinopathy is a
Suprachoroidal_drug_delivery
American health economist
Managed Care. Greenwood Publishing Group. pp. 69–. ISBN 978-0-86569-263-3. "Anti-VEGF Treats Wet Macular Degeneration". Today's Geriatric Medicine, By Jennifer
Frank_A._Sloan
Chinese-born Swedish scientist and professor
Jones, Bernt; Wu, Yan; Zhu, Zhenping; Pytowski, Bronislaw (2008-11-25). "Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated
Yihai_Cao
Stem cell in bone marrow that gives rise to endothelial cells
cancerous cells do this by secreting factors such as VEGF and by reducing the amount of PGK, an anti-VEGF enzyme. The result is an uncontrolled production
Endothelial_stem_cell
Medical condition
"Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography". Eye and
Intraretinal microvascular abnormalities
Intraretinal_microvascular_abnormalities
Formation of blood vessels
Anti-angiogenic therapies are currently used in combination with other therapies for cancer management. Bevacizumab, a monoclonal antibody & VEGF inhibitor
Vascularisation
Signaling within the same cell
that are VEGF-dependent, challenging the belief that VEGF's role in cancer is limited to angiogenesis. Instead, this research suggests that VEGF receptor-targeted
Autocrine_signaling
American biotechnology company
a VEGF-trap. The company was founded by CEO Leonard Schleifer and scientist George Yancopoulos in 1988. Regeneron has developed aflibercept, a VEGF inhibitor
Regeneron_Pharmaceuticals
Indian ophthalmologist
Vitreoretinal surgery, Ophthalmic Lasers, Uveal diseases, Macular Hole surgery, anti-VEGF injections, Age Related Macular Degeneration, Retinal Detachment surgery
Atul_Kumar_(ophthalmologist)
Protein with antiangiogenic properties
non-membrane associated splice variant of VEGF receptor 1 (Flt-1), sFlt-1 binds the angiogenic factors VEGF (vascular endothelial growth factor) and PlGF
Soluble fms-like tyrosine kinase-1
Soluble_fms-like_tyrosine_kinase-1
ANTI VEGF
ANTI VEGF
ANTI VEGF
ANTI VEGF
ANTI VEGF
ANTI VEGF
ANTI VEGF
ANTI VEGF
ANTI VEGF